论文部分内容阅读
目的:讨论孕妇在孕前期体重指数(BMI)、孕期BMI的增幅与妊娠高血压子痫前期、巨大儿及分娩结局的关系。方法:随机选择在我院住院的孕妇400例,依据孕前BMI分为正常组、超重组、肥胖组等三组,依据整个孕期的BMI涨幅,分为Ⅰ组(BMI的涨幅<4)、Ⅱ组(4≤BMI的涨幅≤6)、Ⅲ组(BMI的涨幅>6)。并对各组与妊娠高血压子痫前期、巨大儿及分娩结局之间的关系作一下简单研究。结果:超重组、肥胖组、Ⅱ组、Ⅲ组在妊娠高血压子痫前期、巨大儿及胎儿窘迫与难产的发生率高于正常组很多。具有统计学意义(P<0.05)。结论:孕前期及孕期BMI的涨幅与妊娠高血压子痫前期、巨大儿及分娩结局之间的关系很密切,因此控制孕前期及孕期BMI的涨幅能降低妊娠高血压子痫前期、巨大儿及胎儿窘迫与难产的发生率。
Objective: To discuss the relationship between pregnant women ’s body mass index (BMI) during pregnancy and the increase of BMI during pregnancy and the outcome of preeclampsia, macrosomia and delivery. Methods: Four hundred pregnant women were randomly selected in our hospital. According to BMI before pregnancy, they were divided into three groups: normal group, overweight group and obesity group. According to the increase of BMI in the whole pregnancy, they were divided into group Ⅰ (BMI increase <4), Ⅱ Group (4 ≤ BMI increase ≤ 6), Group Ⅲ (BMI increase> 6). And each group and pregnancy-induced hypertension preeclampsia, macrosomia, and the relationship between delivery outcomes for a brief study. Results: The incidence of fetal distress and dystocia in overweight, obesity, group Ⅱ and group Ⅲ were significantly higher than those in normal group in gestational hypertension and preeclampsia. Statistically significant (P <0.05). Conclusion: There is a close relationship between the increase of BMI in pre-pregnancy and pregnancy and pregnancy-induced hypertension (PGE), macrosomia and delivery outcomes. Therefore, controlling the increase of BMI during pre-pregnancy and pregnancy can reduce the incidence of pre-eclampsia, macrosomia and Fetal distress and the incidence of dystocia.